← Open Payments lookup

MOUSA BOTROS: Open Payments

NPI 1508248881 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$834 in 34 payments from 6 companies in 2025. Trend: 2023 $25 · 2024 $351 · 2025 $834

Food & beverage: $834
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.11$287
Luye Pharma (USA) Ltd.6$154
Janssen Pharmaceuticals, Inc7$148
Alkermes, Inc.5$126
Otsuka America Pharmaceutical, Inc.3$78
E.R. Squibb & Sons, L.L.C.2$42

Products named: UZEDY, ERZOFRI EXTENDED-RELEASE, INVEGA SUSTENNA, ARISTADA, AUSTEDO XR, ABILIFY MAINTENA, COBENFY, ABILIFY ASIMTUFII.

Industry payments across FL — which companies pay providers there.